SKP2 and prostate cancer: Skp2 is overexpressed and associated with poor prognosis in variety of human cancers, including prostate cancer [4], gastric cancer[5], breast cancer [6, 7], and liver cancer [8], suggesting the oncogenic role of Skp2 in tumorigenesis.